Skip to main content

Closed

EVMN: Evommune, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-899.9%

ROIC-28.7%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-29997.3×

Current ratio20.36×

Evommune, Inc.

EVMNNew York Stock Exchange·USD·Closed

Evommune, Inc.

EVMNNew York Stock Exchange·USD·Closed

$11.25

−0.88%

$11.25

−$0.10 (0.88%)

52W Range

3thpctl

Volume

0.33×avg

Mkt Cap

159.35MUSD

P/E

-4.7TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.33×avg

Market Cap

159.35MUSD

P/E Ratio

-4.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings